We are live on ! Find out more
CAPTRUST Financial Advisors

CAPTRUST Financial Advisors Portfolio holdings

AUM $57.3B
1-Year Est. Return 18.32%
This Fund
S&P 500
This Quarter Est. Return
-0.19%
1 Year Est. Return
+18.32%
3 Year Est. Return
+60%
5 Year Est. Return
+73.18%
10 Year Est. Return
+239.88%
AUM
$12B
AUM Growth
+$1.3B
Cap. Flow
+$1.41B
Cap. Flow %
11.69%
Top 10 Hldgs %
21.62%
Holding
5,128
New
356
Increased
2,123
Reduced
1,134
Closed
292

Sector Composition

Rank Sector Weight
1 Technology 14.37%
2 Financials 9.29%
3 Healthcare 7.53%
4 Industrials 7.27%
5 Consumer Discretionary 6.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPRU icon
3651
Spruce Power Holding Corp
SPRU
$39.1M
$4K ﹤0.01%
82
-42
-34% -$2.24K
TDIV icon
3652
First Trust NASDAQ Technology Dividend Index Fund
TDIV
$4.1B
$4K ﹤0.01%
69
-100
-59% -$5.79K
TGTX icon
3653
TG Therapeutics
TGTX
$8.53B
$4K ﹤0.01%
111
-8
-7% -$248
TISI icon
3654
Team
TISI
$77.7M
$4K ﹤0.01%
146
+38
+35% +$1.83K
TME icon
3655
Tencent Music
TME
$15.3B
$4K ﹤0.01%
500
TRS icon
3656
TriMas Corp
TRS
$1.45B
$4K ﹤0.01%
120
-16
-12% -$494
TVTX icon
3657
Travere Therapeutics
TVTX
$5.27B
$4K ﹤0.01%
+168
New +$3.09K
UFPT icon
3658
UFP Technologies
UFPT
$1.92B
$4K ﹤0.01%
58
+3
+5% +$189
XPH icon
3659
State Street SPDR S&P Pharmaceuticals ETF
XPH
$480M
$4K ﹤0.01%
74
CUTR
3660
DELISTED
Cutera, Inc.
CUTR
$4K ﹤0.01%
77
PFC
3661
DELISTED
Premier Financial Corp. Common Stock
PFC
$4K ﹤0.01%
131
LUMO
3662
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$4K ﹤0.01%
400
SHPW
3663
DELISTED
Shapeways Holdings, Inc. Common Stock
SHPW
$4K ﹤0.01%
63
FUV
3664
DELISTED
Arcimoto, Inc. Common Stock
FUV
$4K ﹤0.01%
+17
New +$4.62K
NGM
3665
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$4K ﹤0.01%
211
+113
+115% +$2.49K
GHL
3666
DELISTED
Greenhill & Co., Inc.
GHL
$4K ﹤0.01%
252
LTRPA
3667
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$4K ﹤0.01%
1,255
+92
+8% +$342
PRTK
3668
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$4K ﹤0.01%
826
HARP
3669
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$4K ﹤0.01%
+52
New +$5.23K
HEXO
3670
DELISTED
HEXO Corp. Common Shares
HEXO
$4K ﹤0.01%
162
-14
-8% -$649
ATCO
3671
DELISTED
Atlas Corp.
ATCO
$4K ﹤0.01%
250
POSH
3672
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
$4K ﹤0.01%
148
COVAW
3673
DELISTED
COVA Acquisition Corp. Warrants to purchase Class A ordinary shares
COVAW
$4K ﹤0.01%
+7,528
New +$5.29K
GHACW
3674
DELISTED
Gaming & Hospitality Acquisition Corp. Warrants
GHACW
$4K ﹤0.01%
5,055
AERI
3675
DELISTED
Aerie Pharmaceuticals
AERI
$4K ﹤0.01%
376

Similar funds

CAPTRUST Financial Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, CAPTRUST Financial Advisors held 5,128 positions worth $12B, up 12% from $10.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

CAPTRUST Financial Advisors deployed $1.41B of net new capital in Q3 2021, opening 356 new positions and adding to 2,123 existing holdings. Its largest new stake was Dimensional World ex US Core Equity 2 ETF: 487,508 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard Total International Stock ETF, an estimated $37.8M trimmed.

  • CAPTRUST Financial Advisors's largest Q3 2021 buy was Dimensional World ex US Core Equity 2 ETF: 487,508 shares worth $12.6M.
  • CAPTRUST Financial Advisors added most to Vanguard S&P 500 ETF in Q3 2021, an estimated $85.8M increase.
  • CAPTRUST Financial Advisors's biggest Q3 2021 reduction was Vanguard Total International Stock ETF, cutting an estimated $37.8M.
  • CAPTRUST Financial Advisors fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $1.73M.
  • CAPTRUST Financial Advisors's ten largest holdings make up 22% of its $12B portfolio in Q3 2021.
  • CAPTRUST Financial Advisors opened 356 new positions and closed 292 in Q3 2021.
  • CAPTRUST Financial Advisors's portfolio value rose 12% quarter-over-quarter to $12B.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.